Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients.

Karen ZaguirreMasaya KaiMakoto KuboMai YamadaKanako KurataHitomi KawajiKazuhisa KaneshiroYurina HaradaSaori HayashiAkiko ShimazakiTakafumi MorisakiHitomi MoriYoshinao OdaSanmei ChenTaiki MoriyamaShuji ShimizuMasafumi Nakamura

Published in: Cancer medicine (2021)

PREDICT tool accurately estimated the 5- and 10-year OS in the overall Japanese study population. However, caution should be used for interpretation of the 5-year OS outcomes in patients that are ≥65 years old, and also for the 10-year OS outcomes in patients that are ≥65 years old, those with histologic grade 3 and Luminal A tumors, and in those considering ETx or no systemic treatment.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
type diabetes
adipose tissue
skeletal muscle
drug induced